每经AI快讯，诺和诺德2月4发布2025年财报。诺和诺德全年销售达到3091亿丹麦克朗，以固定汇率计 算增长10%。司美格鲁肽全系药物全年销售额达到2282.88亿丹麦克朗。降糖版司美格鲁肽注射液 Ozempic(国内商品名诺和泰)销售额1270.89亿丹麦克朗，减重版司美格鲁肽注射液Wegovy(国内商品名 诺和盈)为791.06亿丹麦克朗。降糖版司美格鲁肽口服片剂(国内商品名诺和忻)为220.93亿丹麦克朗。 Wegovy片剂(每日给药一次的口服司美格鲁肽25mg)自1月5日在美上市后，周处方量总计约达50000。 ...

Market Overview - Major U.S. indices closed lower on Tuesday, with the Dow Jones Industrial Average slipping 0.3% to 49,240.99, the S&P 500 falling 0.8% to 6,917.81, and the Nasdaq dropping 1.4% to 23,255.18 [1] Super Micro Computer, Inc. (NASDAQ:SMCI) - Super Micro Computer shares dipped slightly by 0.13%, closing at $29.67, with an intraday high of $30.17 and a low of $28.64, and a 52-week range of $66.44 to $27.35. In after-hours trading, the stock increased by 7.18% to $31.80 [1] Chipotle Mexican Grill (NYSE:CMG) - Chipotle Mexican Grill saw its stock rise by 1.71%, closing at $39.17, with a trading range between $39.20 and $37.83, and a 52-week high of $59.19 and low of $29.75. The stock slid 5.62% to $36.97 in extended trading [2] - Chipotle beat fourth-quarter estimates, posting EPS of 25 cents versus the expected 24 cents, while revenue rose by $139 million year over year [2] PayPal Holdings, Inc. (NASDAQ:PYPL) - PayPal experienced a significant drop of 20.31%, closing at $41.70, with an intraday high of $43.70 and a low of $41.43, matching its 52-week low. The stock rose by 1.25% to $42.22 in after-hours trading [3] Advanced Micro Devices Inc (NASDAQ:AMD) - AMD stock has a value in the 6th percentile according to Benzinga Edge Stock Rankings, while it has a Momentum score in the 93rd percentile [4]

Market Overview - The three major U.S. stock indices closed lower, with the Dow Jones down 0.34%, the Nasdaq down 1.43%, and the S&P 500 down 0.83% [1] - Popular technology stocks experienced declines, with Broadcom falling over 3%, and Microsoft, Nvidia, and Meta each dropping over 2% [1] Sector Performance - The rare earth, non-ferrous metals, and precious metals sectors saw significant gains, with gold resources rising over 20%, Southern Copper up over 11%, Americas Silver up over 8%, and Pan American Silver up over 5% [1] - Conversely, application software, cryptocurrency, and weight loss drug stocks faced notable declines, with Novo Nordisk down over 14%, Coinbase and Circle each down over 4%, and Eli Lilly and Pfizer each down over 3% [1] Notable Company Movements - Walmart's stock increased by 2.94%, marking its market capitalization surpassing the $1 trillion milestone for the first time [1] - The Nasdaq Golden Dragon China Index fell by 0.94%, with significant declines in popular Chinese stocks such as Daqo New Energy down 5.6%, Bilibili down 4%, and Kingsoft Cloud down 3.5% [1] - Alibaba dropped 2.9%, while NIO rose 0.8%, Pony.ai increased by 2%, Huazhu up 2.2%, New Oriental up 2.3%, Li Auto up 2.7%, Canadian Solar up 4.1%, and Xpeng up 4.3% [1]

Brendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Theravance/Aspira) prior to securing employment at Caltech.-First employee and co-founder of 1200 Pharma as it spun out of Caltech garnering major investment (into the 8 figures).-Remains an avid investor, focused on market trends and especially biotechnology stocks.Analyst’s Disclosure: I/w ...

来源：滚动播报 当地时间2月3日，诺和诺德发布公告称，在2026年3月26日的年度股东大会上，董事会将提议2025年期 末股息为每股7.95丹麦克朗，使2025年预期总股息达到11.70丹麦克朗。董事会决定启动一项新的股票回 购计划，规模最高可达150亿丹麦克朗。 ...

Novo Nordisk (NVO) shares crashed on Tuesday after the Danish drugmaker issued a sobering outlook for 2026 that caught Wall Street flat-footed. According to the pharma giant, its top- and bottom-line growth will decelerate this year as its “Most Favored Nations” agreement with the U.S. lowers weight-loss drug prices in its largest market. More News from Barchart At the time of writing, Novo Nordisk stock is trading some 20% below its year-to-date high. www.barchart.com What This 2026 Outlook Really M ...

Market Overview - Stocks declined on Tuesday, with the S&P 500 falling over 1% and the Nasdaq dropping approximately 2% due to a selloff in technology stocks [1] - Financial stocks, including Blue Owl Capital, KKR, Apollo Global Management, and BlackRock, also experienced declines as the market reacted to potential software losers from AI [1] Company-Specific Updates - Nvidia's stock fell more than 3% on Tuesday, maintaining a flat performance over the past six months; CEO Jensen Huang denied rumors of a fraying relationship with OpenAI during an interview with Jim Cramer [1] - Eli Lilly's shares dropped nearly 4% ahead of its earnings report, influenced by Novo Nordisk's disappointing guidance for 2026, which included a projected sales decline of 5% to 13% year over year [1] - Novo Nordisk's stock fell over 15% after announcing it expects lower sales in the U.S. due to price pressures and increasing competition, suggesting a potential loss of market share to Eli Lilly [1] Housing Market Insights - Housing-related stocks saw a rally following a report indicating efforts to make entry-level home buying more affordable, involving companies like Lennar and Taylor Morrison Home [1] - Despite the broader market decline, Home Depot's shares rose nearly 1%, indicating potential benefits from a revived housing market [1] Upcoming Earnings Reports - Key earnings reports expected after Tuesday's close include Advanced Micro Devices, Super Micro, Chipotle, Enphase Energy, Amgen, Amcor, Prudential Financial, Mondelez, and Corteva [1] - Notable reports before Wednesday's opening bell include GE Healthcare, Uber, Boston Scientific, Johnson Controls, AbbVie, Bunge, and Fortive [1]

本文源自：金融界AI电报 诺和诺德2025财年净利润为1024亿丹麦克朗。 ...

Novo Nordisk A/S (NYSE:NVO) stock is trading lower on Tuesday after the weight-loss drug maker released its 2026 full-year sales and operating profit outlook.2026 OutlookNovo Nordisk expects reported 2026 sales and operating profit to benefit from a $4.2 billion reversal of 340B Drug Pricing Program in the U.S. In 2025, $400 million was excluded.Excluding this one-time item, the mid-point of sales and operating profit growth guidance for 2026, both at CER, would be -1% and 11%, respectively.Adjusted sales g ...

The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook. ...